Illumina Inc (ILMN)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $31.30B
Last updated: Nov 17, 2026 at 11:06 AM ET
Illumina Inc (ILMN) Stock Forecast
Analysts expect Illumina (ILMN) to earn $5.48 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.63B. Of 21 analysts, 10 rate the stock Buy or Strong Buy, 7 Hold and 4 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is $6.18.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.67, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 48% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 19.0% |
| Buy | 6 | 28.6% |
| Hold | 7 | 33.3% |
| Sell | 1 | 4.8% |
| Strong Sell | 3 | 14.3% |
- Consensus
- Hold
- Total analysts
- 21
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 12.8% and revenue estimates rise 7.1%.
- Fiscal year ending Dec 31, 2026
- $5.48
- EPS consensus, revenue $4.63B
- Fiscal year ending Dec 31, 2027
- $6.18
- EPS consensus, revenue $4.96B
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.48 | $5.40 to $5.64 | 20 | $4.63B | $4.60B to $4.65B | 19 |
| Dec 31, 2027 | $6.18 | $5.83 to $6.62 | 21 | $4.96B | $4.92B to $5.04B | 16 |
Quarterly Estimates
The EPS consensus falls from $1.56 for the quarter ending Dec 31, 2026 to $1.35 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.56 | $1.48 to $1.64 | 20 | $1.25B | $1.19B to $1.30B | 20 |
| Mar 31, 2027 | $1.35 | $1.28 to $1.53 | 13 | $1.16B | $1.14B to $1.19B | 9 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 10 upward and 4 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 8 | 3 |
| Quarter ending Mar 31, 2027 | 2 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.2% from $5.36.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $5.48 | $5.48 | $5.36 | $5.36 | $5.36 | +2.3% |
| Fiscal year ending Dec 31, 2027 | $6.18 | $6.18 | $6.12 | $6.10 | $6.10 | +1.4% |
| Quarter ending Mar 31, 2027 | $1.35 | $1.35 | $1.33 | $1.32 | $1.33 | +1.8% |
Frequently Asked Questions About ILMN
What is the ILMN stock forecast?
Consensus analyst estimates put Illumina's EPS at $5.48 for the fiscal year ending Dec 31, 2026, on revenue of $4.63B. The consensus rating from 21 analysts is Hold.
How do analysts rate ILMN stock?
Of 21 analysts covering Illumina, 4 rate it Strong Buy, 6 Buy, 7 Hold, 1 Sell and 3 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from ILMN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.48, with estimates from $5.40 to $5.64 from 20 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.18, with estimates from $5.83 to $6.62 from 21 analysts.
What revenue do analysts expect from Illumina next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.63B, with estimates from $4.60B to $4.65B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $4.96B, with estimates from $4.92B to $5.04B.
How many analysts cover ILMN?
21 analysts rate Illumina stock, and 20 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ILMN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts